Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation

Klompenhouwer, Elisabeth G; Dresen, Raphaëla C; Verslype, Chris; Laenen, Annouschka; De Hertogh, Gert; Deroose, Christophe; Bonne, Lawrence; Vandecaveye, Vincent; Maleux, Geert

doi:10.1007/s00270-017-1739-5

Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation

Author:

Klompenhouwer, Elisabeth G

Dresen, Raphaëla C ; Verslype, Chris ; Laenen, Annouschka ; De Hertogh, Gert ; Deroose, Christophe ; Bonne, Lawrence ; Vandecaveye, Vincent ; Maleux, Geert

Keywords:

Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Radiology, Nuclear Medicine & Medical Imaging, Cardiovascular System & Cardiology, HCC, Chemoembolisation, Radioembolisation, Yttrium-90, Microspheres, Survival, Adverse events, Selective internal radiation therapy, LIVER-TRANSPLANTATION, RADIOEMBOLIZATION, MICROSPHERES, CANCER, RECOMMENDATIONS, BRACHYTHERAPY, MALIGNANCIES, GUIDELINES, MANAGEMENT, SORAFENIB, Adult, Aged, Aged, 80 and over, Carcinoma, Hepatocellular, Embolization, Therapeutic, Female, Humans, Liver Neoplasms, Male, Middle Aged, Survival Analysis, Treatment Outcome, Yttrium Radioisotopes, 1102 Cardiorespiratory Medicine and Haematology, Nuclear Medicine & Medical Imaging, 3201 Cardiovascular medicine and haematology

Abstract:

Transarterial chemoembolisation (TACE) is the most widely used locoregional treatment for patients with an unresectable hepatocellular carcinoma (HCC). Transarterial radioembolisation (TARE) with yttrium-90 containing microspheres is an emerging interventional treatment that could be complementary or an alternative to TACE.